Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04196907 · ClinicalTrials.gov registry record
Rad-67 Repeatability and Reproducibility
A clinical trial, sponsored by Masimo Corporation.
- Completed
- Registry status
- 20
- Enrollment target
NCT04196907: Completed study, sponsored by Masimo Corporation.
NCT04196907 is a clinical trial that has completed, run by Masimo Corporation. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04196907 has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The primary objective of this clinical investigation is to evaluate the repeatability and reproducibility of using Rad-67 Pulse CO-Oximeter
Primary Outcome
Quality of hemoglobin measurements is defined as a variance ratio of total Gage repeatability and reproducibility variance to total variance. Subject, operator and device were considered as components to calculate this ratio.
Interventions
- DEVICE Rad-67 Pulse CO-Oximeter and DCI Mini sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-11-19 |
| Est. Completion | 2019-11-20 |
What the finished NCT04196907 record still lists
NCT04196907 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Rad-67 Pulse CO-Oximeter and DCI Mini sensor is the first listed.
NCT04196907 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04196907 about?
NCT04196907 is a clinical study titled "Rad-67 Repeatability and Reproducibility". The primary objective of this clinical investigation is to evaluate the repeatability and reproducibility of using Rad-67 Pulse CO-Oximeter
What is the current status of trial NCT04196907?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2019-11-19. Estimated completion is 2019-11-20.
What interventions are being tested in trial NCT04196907?
The interventions under investigation include: Rad-67 Pulse CO-Oximeter and DCI Mini sensor (DEVICE).
Who is sponsoring clinical trial NCT04196907?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI